Questcor Pharmaceuticals Inc (QCOR)

93.60
1.52 1.65
NASDAQ : Health Care
Prev Close 92.08
Open 92.93
Day Low/High 92.17 / 94.42
52 Wk Low/High 47.71 / 97.80
Volume 3.18M
Avg Volume 1.57M
Exchange NASDAQ
Shares Outstanding 61.45M
Market Cap 5.75B
EPS 4.99
P/E Ratio 16.10
Div & Yield 1.20 (1.30%)
2 Big Stocks the Crowd Is Talking About

2 Big Stocks the Crowd Is Talking About

Here's how to trade some of the most active names on the market today.

Questcor Pharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Mallinckrodt

Questcor Pharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Mallinckrodt

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Questcor...

Mallinckrodt to Buy Questcor: 5 Deals That Blew Up the Short-Sellers

Mallinckrodt to Buy Questcor: 5 Deals That Blew Up the Short-Sellers

Questcor Pharmaceuticals has been a controversial stock for years, as short selling research firm Citron Research raised concerns about the company's Acthar gel, which is marketed for multiple sclerosis and other autoimmune and inflammatory disorders.

QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Questcor Pharmaceuticals Inc. (QCOR) Over The Proposed Sale Of The Company To Mallinckrodt Plc (MNK)

QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Questcor Pharmaceuticals Inc. (QCOR) Over The Proposed Sale Of The Company To Mallinckrodt Plc (MNK)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Questcor Pharmaceuticals Inc.

Mallinckrodt Acquires Questcor for $5.6B

Mallinckrodt Acquires Questcor for $5.6B

Irish specialty pharma plans to take California target's Acthar gel international.

Investors See More Biotech Consolidation After Questcor Buy: StockTwits.com

Investors See More Biotech Consolidation After Questcor Buy: StockTwits.com

Investors on StockTwits.com believe Monday's $5.6 billion merger between Mallinckrodt and Questcor Pharmaceuticals will spur more acquisitions and support valuations in the biotech sector. Here are some of the other companies singled out as takeout targets.

Greenberg: Questcor Smart Seller, Mallinckrodt Dumb Buyer?

Greenberg: Questcor Smart Seller, Mallinckrodt Dumb Buyer?

Whenever you see a deal like Mallinckrodt buying Questcor, you have to ask: Is this a case of smart seller, dumb buyer? I've done zero work on Questcor, but over the past few years I've talked to a few very serious short-sellers who have. When I saw the news this morning, the first thing that crossed my mind: Mattel buying The Learning Company....Hewlett Packard buying Autonomy...Medtronic buying Arterial Vascular Engineering. All three of the targets were the focus of short-sellers, and all three famously blew up, or otherwise caused havoc, once inside the new parent -- for the very reason the short-sellers had been short. Mattel was perhaps the most wounded, and almost taken down by what it found once it owned The Learning Company. No idea if that will happen here, but a quick peek at Mallinckrodt's history sure is a twisted tale....

Mallinckrodt Grabs Questcor for $5.6B, Sends Shares Surging

Mallinckrodt Grabs Questcor for $5.6B, Sends Shares Surging

Shares of Questcor surge before market open on Monday after it announces a $5.6 billion deal to be acquired by Mallinckrodt.

Market Hustle: Stock Futures Slip as Earnings Season Unfolds

Market Hustle: Stock Futures Slip as Earnings Season Unfolds

U.S. stock futures are pointing to a lower open on Wall Street Monday, extending Friday's selloff.

Questcor Pharmaceuticals (QCOR) Rising Before The Market Opens

Questcor Pharmaceuticals (QCOR) Rising Before The Market Opens

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a pre-market leader candidate

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals was a winner within the drugs industry, rising $3.04 (4.4%) to $72.17 on average volume

QCOR May 23rd Options Begin Trading

QCOR May 23rd Options Begin Trading

Investors in Questcor Pharmaceuticals Inc saw new options become available today, for the May 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the QCOR options chain for the new May 23rd contracts and identified one put and one call contract of particular interest.

'Mad Money' Lightning Round: Don't Buy eBay

'Mad Money' Lightning Round: Don't Buy eBay

Cramer says he's disappointed by Volaris, missed on Endocyte but likes GNC Holdings and Chicago Mercantile Exchange.

Jim Cramer's 'Mad Money' Recap: Out With a Bang

Jim Cramer's 'Mad Money' Recap: Out With a Bang

Cramer says the only thing shocking about Michael Lewis's new book on high-frequency trading is that people find it shocking at all.

Off the Charts

Off the Charts

America Movil is showing significant relative weakness this year.

Lagging In Post-Market Activity: Questcor Pharmaceuticals (QCOR)

Lagging In Post-Market Activity: Questcor Pharmaceuticals (QCOR)

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a post-market laggard candidate

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner

Questcor Pharmaceuticals was a winner within the health care sector, rising $0.75 (1.2%) to $64.14 on light volume

Interesting QCOR Put And Call Options For May 2nd

Interesting QCOR Put And Call Options For May 2nd

Investors in Questcor Pharmaceuticals Inc saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the QCOR options chain for the new May 2nd contracts and identified one put and one call contract of particular interest.

'Mad Money' Lightning Round: Stay Away From Questcor Pharmaceuticals

'Mad Money' Lightning Round: Stay Away From Questcor Pharmaceuticals

Cramer would rather buy Talisman Energy than sell it and he feels good about Drew Industries.

Jim Cramer's 'Mad Money' Recap: Stop Panicking

Jim Cramer's 'Mad Money' Recap: Stop Panicking

Ukraine is just another in a long list of foreign crises that have the markets operating on emotion instead of logic, Cramer says.

Today's Dead Cat Bounce Stock Is Questcor Pharmaceuticals (QCOR)

Today's Dead Cat Bounce Stock Is Questcor Pharmaceuticals (QCOR)

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a "dead cat bounce" (down big yesterday but up big today) candidate

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals was a leading decliner within the drugs industry, falling $6.74 (-9.1%) to $67.47 on heavy volume

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Move To Ireland Could Boost Questcor's M&A

Move To Ireland Could Boost Questcor's M&A

Questcor Pharmaceuticals could be moving to Ireland in the next year to help it save cash that could be deployed for acquisitions, according to an industry analyst.

Questcor Pharmaceuticals (QCOR) Is Water-Logged And Getting Wetter Today

Questcor Pharmaceuticals (QCOR) Is Water-Logged And Getting Wetter Today

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Lagging In Post-Market Activity: Questcor Pharmaceuticals (QCOR)

Lagging In Post-Market Activity: Questcor Pharmaceuticals (QCOR)

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a post-market laggard candidate

Barrow Fund Sees Safe Returns in Smith & Wesson, Raytheon

Barrow Fund Sees Safe Returns in Smith & Wesson, Raytheon

Companies in the Barrow All-Cap Core Fund are merger targets four times more than the market at large because the fund's managers take a private equity approach to stock-picking.

April 4th Options Now Available For Questcor Pharmaceuticals (QCOR)

April 4th Options Now Available For Questcor Pharmaceuticals (QCOR)

Investors in Questcor Pharmaceuticals Inc saw new options begin trading today, for the April 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the QCOR options chain for the new April 4th contracts and identified one put and one call contract of particular interest.